MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 21 to 40 of 166,322 approvalsPage 2 of 8317

Piracetam Injection

Approval Number: 国药准字H20254518
Registration: Jun 10, 2025

Famotidine Injection

Approval Number: 国药准字H20254501
Registration: Jun 10, 2025

Isosorbide Dinitrate Injection

Approval Number: 国药准字H20254468
Registration: Jun 10, 2025

Sacubitril Valsartan Sodium Tablets

Approval Number: 国药准字H20254531
Registration: Jun 10, 2025

Oxacillin Sodium for Injection

Approval Number: 国药准字H20254495
Registration: Jun 10, 2025

Urapidil Hydrochloride Injection

Approval Number: 国药准字H20254524
Registration: Jun 10, 2025

Nicorandil for Injection

Approval Number: 国药准字H20254521
Registration: Jun 10, 2025

Procaterol Hydrochloride Inhalation Solution

Approval Number: 国药准字H20254534
Registration: Jun 10, 2025

Dopamine Hydrochloride Injection

Approval Number: 国药准字H20254504
Registration: Jun 10, 2025

Procaterol Hydrochloride Oral Solution

Approval Number: 国药准字H20254528
Registration: Jun 10, 2025

Lansoprazole Enteric-coated Capsules

Approval Number: 国药准字HJ20250069
Registration: Jun 10, 2025

Levocarnitine Oral Solution

Approval Number: 国药准字H20254530
Registration: Jun 10, 2025

Dopamine Hydrochloride Injection

Approval Number: 国药准字H20254503
Registration: Jun 10, 2025

Ibuprofen Suspension

Approval Number: 国药准字H20254482
Registration: Jun 10, 2025

Rivastigmine Transdermal Patch

Approval Number: 国药准字H20254469
Registration: Jun 10, 2025

Nilotinib Capsules

Approval Number: 国药准字HJ20250067
Registration: Jun 3, 2025

Potassium Chloride Granules

Approval Number: 国药准字H20254412
Registration: Jun 3, 2025

Benidipine Hydrochloride Tablets

Approval Number: 国药准字H20254437
Registration: Jun 3, 2025

Lacosamide Tablets

Approval Number: 国药准字H20254452
Registration: Jun 3, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.